{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:24:03Z","timestamp":1771014243206,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Gen Psychiatry"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Despite multiple antidepressant options, major depressive disorder (MDD) still faces high non-response rates, eventually requiring anticonvulsant augmentation strategies too. The aim of this study was to explore such a potential role for zonisamide.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 40 MDD outpatients diagnosed using the<jats:italic>Diagnostic and Statistical Manual for Mental Disorders<\/jats:italic>, fourth edition criteria entered a 24 week open trial receiving duloxetine 60 mg\/day for the first 12 weeks and subsequently (weeks 12 to 24) augmentation with zonisamide 75 mg\/day if they did not respond to the initial monotherapy. Efficacy and tolerability were assessed using the Hamilton Scales for Anxiety and Depression (a 12 week score \u226550% vs baseline defined 'non-response'), the Arizona Sexual Experience Scale, the Patient Rated Inventory of Side Effects and the Young Mania Rating Scale.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At week 12, 15 patients out of 39 (38.5%) were responders, and 1 had dropped out; remarkably, 14 patients out of 24 (58.3%) had achieved response by week 24. Poor concentration and general malaise were associated with non-response both at week 12 and 24 (P = 0.001), while loss of libido and reduced energy were prominent among final timepoint non-responders. Patients receiving zonisamide also experienced weight reduction (2.09 \u00b1 12.14 kg; P = 0.001) independently of the outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Although only a preliminary study due to strong methodological limitations, and thus requiring confirmation by further controlled investigations, the current results indicate zonisamide may be a potential augmentation option for some depressed patients receiving low doses of duloxetine.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1744-859x-10-23","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T08:56:12Z","timestamp":1316508972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: preliminary results on tolerability and clinical effects"],"prefix":"10.1186","volume":"10","author":[{"given":"Michele","family":"Fornaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Dalmasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Colicchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzia","family":"Benvenuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Escelsior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Perugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,19]]},"reference":[{"key":"1301_CR1","doi-asserted-by":"publisher","first-page":"580","DOI":"10.12968\/hosp.2002.63.10.1925","volume":"63","author":"A Tylee","year":"2002","unstructured":"Tylee A, Walters P: The burden of depression. Hosp Med. 2002, 63: 580-581.","journal-title":"Hosp Med"},{"key":"1301_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2174\/1745017901006010020","volume":"6","author":"M Fornaro","year":"2010","unstructured":"Fornaro M, Giosue P: Current nosology of treatment resistant depression: a controversy resistant to revision. Clin Pract Epidemiol Ment Health. 2010, 6: 20-24. 10.2174\/1745017901006010020.","journal-title":"Clin Pract Epidemiol Ment Health"},{"issue":"Suppl 18","key":"1301_CR3","first-page":"4","volume":"62","author":"M Fava","year":"2001","unstructured":"Fava M: Augmentation and combination strategies in treatment-resistant depression. J Clin Psychiatry. 2001, 62 (Suppl 18): 4-11.","journal-title":"J Clin Psychiatry"},{"key":"1301_CR4","first-page":"34","volume":"41","author":"T Petersen","year":"2008","unstructured":"Petersen T, Perlis RH, Ticknor C, Lohr J, Solvason HB, O'Reardon JP, Wohlreich MM, Andreotti C, Wilson M, Fava M: Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trial. Psychopharmacol Bull. 2008, 41: 34-45.","journal-title":"Psychopharmacol Bull"},{"key":"1301_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/jcp.0b013e318059361a","volume":"27","author":"M Mula","year":"2007","unstructured":"Mula M, Pini S, Cassano GB: The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J Clin Psychopharmacol. 2007, 27: 263-272. 10.1097\/jcp.0b013e318059361a.","journal-title":"J Clin Psychopharmacol"},{"key":"1301_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4088\/JCP.v58n0806b","volume":"58","author":"NF Feiner","year":"1997","unstructured":"Feiner NF: Antiepileptic drug augmentation for treatment-resistant depression. J Clin Psychiatry. 1997, 58: 361-363.","journal-title":"J Clin Psychiatry"},{"key":"1301_CR7","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1212\/WNL.0b013e3181bd6bd4","volume":"73","author":"A Janati","year":"2009","unstructured":"Janati A, Shneker BF, Cios JS, Elliott JO: Suicidality, depression screening, and antiepileptic drugs: reaction to the FDA alert. Neurology. 2009, 73: 1710-10.1212\/WNL.0b013e3181bd6bd4.","journal-title":"Neurology"},{"key":"1301_CR8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.yebeh.2010.08.030","volume":"19","author":"X Wen","year":"2010","unstructured":"Wen X, Meador KJ, Loring DW, Eisenschenk S, Segal R, Hartzema AG: Is antiepileptic drug use related to depression and suicidal ideation among patients with epilepsy?. Epilepsy Behav. 2010, 19: 494-500. 10.1016\/j.yebeh.2010.08.030.","journal-title":"Epilepsy Behav"},{"key":"1301_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/09638230903469269","volume":"19","author":"SP Thomas","year":"2010","unstructured":"Thomas SP, Nandhra HS, Jayaraman A: Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD). J Ment Health. 2010, 19: 168-175. 10.3109\/09638230903469269.","journal-title":"J Ment Health"},{"key":"1301_CR10","volume-title":"Diagnostic and Statistical Manual for Mental Disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual for Mental Disorders. 1994, Washington, DC: American Psychiatric Association, Fourth","edition":"Fourth"},{"key":"1301_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0920-1211(92)90065-2","volume":"13","author":"H Cheung","year":"1992","unstructured":"Cheung H, Kamp D, Harris E: An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res. 1992, 13: 107-112. 10.1016\/0920-1211(92)90065-2.","journal-title":"Epilepsy Res"},{"key":"1301_CR12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-3565(25)38428-4","volume":"266","author":"DG Lang","year":"1993","unstructured":"Lang DG, Wang CM, Cooper BR: Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J Pharmacol Exp Ther. 1993, 266: 829-835.","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 8","key":"1301_CR13","first-page":"5","volume":"64","author":"HS White","year":"2003","unstructured":"White HS: Mechanism of action of newer anticonvulsants. J Clin Psychiatry. 2003, 64 (Suppl 8): 5-8.","journal-title":"J Clin Psychiatry"},{"key":"1301_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0920-1211(95)00078-X","volume":"22","author":"M Okada","year":"1995","unstructured":"Okada M, Kaneko S, Hirano T, Mizuno K, Kondo T, Otani K, Fukushima Y: Effects of zonisamide on dopaminergic system. Epilepsy Res. 1995, 22: 193-205. 10.1016\/0920-1211(95)00078-X.","journal-title":"Epilepsy Res"},{"key":"1301_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0920-1211(98)00109-0","volume":"34","author":"M Okada","year":"1999","unstructured":"Okada M, Hirano T, Kawata Y, Murakami T, Wada K, Mizuno K, Kondo T, Kaneko S: Biphasic effects of zonisamide on serotonergic system in rat hippocampus. Epilepsy Res. 1999, 34: 187-197. 10.1016\/S0920-1211(98)00109-0.","journal-title":"Epilepsy Res"},{"key":"1301_CR16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1211\/002235703765344603","volume":"55","author":"G Sobieszek","year":"2003","unstructured":"Sobieszek G, Borowicz KK, Kimber-Trojnar Z, Malek R, Piskorska B, Czuczwar SJ: Zonisamide: a new antiepileptic drug. Pol J Pharmacol. 2003, 55: 683-689.","journal-title":"Pol J Pharmacol"},{"key":"1301_CR17","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/j.1742-1241.2007.01365.x","volume":"61","author":"G Kinrys","year":"2007","unstructured":"Kinrys G, Vasconcelos e Sa D, Nery F: Adjunctive zonisamide for treatment refractory anxiety. Int J Clin Pract. 2007, 61: 1050-1053. 10.1111\/j.1742-1241.2007.01365.x.","journal-title":"Int J Clin Pract"},{"key":"1301_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1358\/dot.2010.46.4.1490077","volume":"46","author":"M Murata","year":"2010","unstructured":"Murata M: Zonisamide: a new drug for Parkinson's disease. Drugs Today (Barc). 2010, 46: 251-258. 10.1358\/dot.2010.46.4.1490077.","journal-title":"Drugs Today (Barc)"},{"key":"1301_CR19","first-page":"371","volume":"47","author":"S Kaneko","year":"1993","unstructured":"Kaneko S, Okada M, Hirano T, Kondo T, Otani K, Fukushima Y: Carbamazepine and zonisamide increase extracellular dopamine and serotonin levels in vivo, and carbamazepine does not antagonize adenosine effect in vitro: mechanisms of blockade of seizure spread. Jpn J Psychiatry Neurol. 1993, 47: 371-373.","journal-title":"Jpn J Psychiatry Neurol"},{"key":"1301_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960, 23: 56-62. 10.1136\/jnnp.23.1.56.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1301_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0165-1781(98)00038-9","volume":"79","author":"J Ventura","year":"1998","unstructured":"Ventura J, Liberman RP, Green MF, Shaner A, Mintz J: Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I\/P). Psychiatry Res. 1998, 79: 163-173. 10.1016\/S0165-1781(98)00038-9.","journal-title":"Psychiatry Res"},{"key":"1301_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol. 1959, 32: 50-55. 10.1111\/j.2044-8341.1959.tb00467.x.","journal-title":"Br J Med Psychol"},{"key":"1301_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978, 133: 429-435. 10.1192\/bjp.133.5.429.","journal-title":"Br J Psychiatry"},{"key":"1301_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/009262300278623","volume":"26","author":"CA McGahuey","year":"2000","unstructured":"McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, Manber R: The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther. 2000, 26: 25-40. 10.1080\/009262300278623.","journal-title":"J Sex Marital Ther"},{"key":"1301_CR25","unstructured":"STAR*D Project: Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project. [http:\/\/www.edc.pitt.edu\/stard\/public\/assessment_forms.html]"},{"key":"1301_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/01.pra.0000344918.51404.1e","volume":"15","author":"SH Preskorn","year":"2009","unstructured":"Preskorn SH: Results of the STAR*D study: implications for clinicians and drug developers. J Psychiatr Pract. 2009, 15: 45-49. 10.1097\/01.pra.0000344918.51404.1e.","journal-title":"J Psychiatr Pract"}],"container-title":["Annals of General Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1744-859X-10-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T18:08:00Z","timestamp":1741716480000},"score":1,"resource":{"primary":{"URL":"https:\/\/annals-general-psychiatry.biomedcentral.com\/articles\/10.1186\/1744-859X-10-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,19]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1301"],"URL":"https:\/\/doi.org\/10.1186\/1744-859x-10-23","relation":{},"ISSN":["1744-859X"],"issn-type":[{"value":"1744-859X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,19]]},"assertion":[{"value":"5 June 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"23"}}